Search Results - "WEISELBERG, L"

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium by Sternberg, C N, Yagoda, A, Scher, H I, Watson, R C, Herr, H W, Morse, M J, Sogani, P C, Vaughan, Jr, E D, Bander, N, Weiselberg, L R

“…Of 92 patients who received methotrexate, vinblastine, doxorubicin and cisplatin complete and partial remissions were observed in 69 +/- 10 per cent of 83…”
Get more information

5-Year Results of Dose-Intensive Sequential Adjuvant Chemotherapy for Women With High-Risk Node-Positive Breast Cancer: A Phase II Study by HUDIS, C, FORNIER, M, MOYNAHAN, M, RAPTIS, G, SKLARIN, N, THEODOULOU, M, WEISELBERG, L, SALVAGGIO, R, PANAGEAS, K. S, YAO, T. J, NORTON, L, RICCIO, L, LEBWOHL, D, CROWN, J, GILEWSKI, T, SURBONE, A, CURRIE, V, SEIDMAN, A, REICHMAN, B

“…We conducted a phase II pilot study of dose-intensive adjuvant chemotherapy with doxorubicin followed sequentially by high-dose cyclophosphamide to determine…”
Get full text

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia by STHOEGER, Z. M, WAKAI, M, TSE, D. B, VINCIGUERRA, V. P, ALLEN, S. L, BUDMAN, D. R, LICHTMAN, S. M, SCHULMAN, P, WEISELBERG, L. R, CHIORAZZI, N

“…CD5-expressing B lymphocytes from patients with selected chronic lymphoproliferative disorders were used to determine whether monoclonal populations of CD5+…”
Get full text

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium by Sternberg, C N, Yagoda, A, Scher, H I, Watson, R C, Ahmed, T, Weiselberg, L R, Geller, N, Hollander, P S, Herr, H W, Sogani, P C

“…The M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) regimen was used to treat 25 patients with transitional cell carcinoma of the urothelial…”
Get more information

A phase I study of sequential vinorelbine followed by paclitaxel by Budman, D. R., Weiselberg, L., O'Mara, V., Buchbinder, A., Lichtman, S. M., Donahue, L., Adams, L. M.

“…Background: In vitro experiments suggest that administration of vinorelbine preceding paclitaxel results in synergistic cytotoxic effects. A phase I dose…”
Get full text

Re: Severe Neurotoxicity in Vinorelbine-Paclitaxel Combinations by Budman, Daniel R., Weiselberg, Lora, O'Mara, Vivian

Get full text

Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 by Gal, D, Weiselberg, L, Runowicz, C D

Get more information

Lapatinib Restores Endocrine Sensitivity in Selected Patients with Estrogen Receptor (ER) Positive Metastatic Breast Cancer by Schwartz, G., Borges, V., Weiselberg, L., Elias, A., Budman, D.

“…Background:Breast cancer cell lines achieve a state of resistance to antiestrogens and to estrogen withdrawal or aromatase inhibitors by utilizing other growth…”
Get full text

Cis-platinum chemotherapy for ocular basal cell carcinoma by Morley, M., Finger, P. T., Perlin, M., Weiselberg, L. R., DeBlasio, D. S.

“…We have used intravenous cis-platinum chemotherapy in the treatment of three patients with basal cell carcinoma of the lid extending into the orbit…”
Get full text

P2-13-02: Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis by Shapira, I, Budman, DR, Akerman, M, Weiselberg, L, Vinciguerra, V, D'Olimpio, J, Devoe, C, Cheng, KL, Donahue, L, John, V, Cohen, S

“…Background: Genetic diseases may display parent-of-origin effects. In such cases, the risk depends on the specific parent or origin allele. Imprinting effect…”
Get full text

Study of the major phenotype of large granular T-cell lymphoproliferative disorder by Sun, T, Brody, J, Koduru, P, Vinciguerra, V, Weiselberg, L, Marino, J, Chaudhri, F, Papps, J, Erickson, R

“…Six cases of large granular T-cell lymphoproliferative disorder with a selected immunophenotype (CD3+, CD4-, CD8+, CD16+) were studied to characterize a…”
Get more information

Determining Issues of Importance for Patients with Breast Cancer: Results of a Web-Based Study in 1072 Patients To Enhance the Content Validity for the Development of a New Health-Related Quality of Life (Ql) Instrument, the Breast Cancer Symptom Scale (BCSS) by Weiselberg, L., Gralla, R., Horigan, J., Davis, B., Hollen, P., Petersen, J., Burg, K., Belland, A.

“…Background:Identifying key issues for patients with malignancy is central to assessing QL and patient reported outcomes during all points of the illness…”
Get full text

Does maternal or paternal inheritance of BRCA mutation affect the age of cancer diagnosis? by Shapira, I., Gralla, R. J., Akerman, M., Weiselberg, L. R., John, V. S., Raftopoulos, H., Vinciguerra, V., Lovecchio, J. L., Menzin, A., Cohen, S.

“…Abstract only…”
Get full text

Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study by Janelsins, Michelle C, Heckler, Charles E, Peppone, Luke J, Kamen, Charles, Mustian, Karen M, Mohile, Supriya G, Magnuson, Allison, Kleckner, Ian R, Guido, Joseph J, Young, Kelley L, Conlin, Alison K, Weiselberg, Lora R, Mitchell, Jerry W, Ambrosone, Christine A, Ahles, Tim A, Morrow, Gary R

“…Purpose Cancer-related cognitive impairment is an important problem for patients with breast cancer, yet its trajectory is not fully understood. Some previous…”
Get full text

Abstract P2-10-05: Referral to Genetic Services (GS) and Mutation Yield in 1132 Individuals at Risk for Hereditary Breast Ovarian Cancer Syndromes (HBOC) by Shapira, I, Gralla, R, Weiselberg, L, Vinciguerra, V, Raftopoulos, H, Carleton, J, Budman, D, Conte, C, Beg, M, Kadison, A, Zaidi, R, Wang, J, Filardi, D, Cohen, S.

“…Background: Family history directs referral of unaffected individuals to GS and is the main strategy to identify hereditary breast ovarian cancer syndrome. In…”
Get full text

Pharmacokinetic evaluation of zeniplatin in humans by DEMARCO, L. C, BUDMAN, D. R, HOFFMAN, A, KANTROWITZ, J, RASTOGI, R, LATHIA, C, AMORUSI, P, BIRKHOFER, M, LICHTMAN, S, WEISELBERG, L, VINCIGUERRA, V, LOVECCHIO, J, GAL, D

“…Zeniplatin, a more water-soluble organoplatinum than cisplatin, was evaluated for clinical pharmacology in the context of a phase II trial in previously…”
Get full text

Stereologic analysis of monocytes and their subcellular organelles in patients with acute monocytic and myelomonocytic leukemia by Weiselberg, L, Matulonis, U, McGarvey, E, Roberts, B, Lichtman, S, Allen, S, Vinciguerra, V, Teichberg, S

“…The stereologic characteristics of monocytes from patients with acute nonlymphocytic leukemia containing a monocytic component (FAB M4 and M5), and the…”
Get more information

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse by Sternberg, C N, Yagoda, A, Scher, H I, Watson, R C, Geller, N, Herr, H W, Morse, M J, Sogani, P C, Vaughan, E D, Bander, N

“…Of 133 patients with advanced urothelial tract cancer given methotrexate (MTX), vinblastine (VBL), Adriamycin (ADR) (doxorubicin; Adria Laboratories, Columbus,…”
Get more information

Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma by Schulman, P, Budman, D R, Weiselberg, L, Vinciguerra, V, Degnan, T J

“…A phase II trial of mitomycin, vinblastine, and cisplatin was undertaken in 26 patients with non-small cell carcinoma of the lung. A major response rate of 46%…”
Get more information

Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature by Weiselberg, L, Budman, D, Vinciguerra, V, Schulman, P, Degnan, T J

“…Estrogen receptors have been demonstrated in human hypernephroma (renal cell carcinoma). Antiestrogens have been demonstrated to have antitumor activity in…”
Get more information